Exploring the Intersection between Childhood Cancer and Birth Defects to Identify Novel Cancer Predisposition Syndromes |
Baylor College of Medicine / Philip Lupo, PhD |
Epidemiology Grants |
2014 |
Texas |
Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells |
Baylor College of Medicine / Leonid S. Metelitsa, M.D., Ph.D. |
Bio-Therapeutic Impact Award |
2014 |
Texas |
Characterization and Targeting of p53 Ubiquitination in Neuroblastoma.
|
Baylor College of Medicine / Eveline Barbieri, MD, PhD |
Young Investigator Grants |
2008 |
Texas |
Parallel sequencing to identify the causes of childhood cancer.
|
Baylor College of Medicine / Sharon Plon, MD, PhD |
Innovation Grants |
2006 |
Texas |
Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene |
Baylor College of Medicine / Robin Parihar, MD, PhD |
Young Investigator Grants |
2015 |
Texas |
Treatment of high-risk pediatric brain tumors with a CD133-targeted adenovirus in combination with temozolomide
|
University of Texas M.D. Anderson Cancer Center / Marta Alonso, PhD |
Young Investigator Grants |
2008 |
Texas |
Strategies for Epigenetically Reprogramming Neuroblastoma Cancer Stem Cells |
Baylor College of Medicine / Jason Shohet, MD, PhD |
Innovation Grants |
2011 |
Texas |
DICER1-Driven Cancers: Models, Mechanisms and Therapies |
University of Texas Southwestern Medical Center at Dallas / James Amatruda, MD/PhD |
Innovation Grants |
2016 |
Texas |
Screening for New Rhabdomyosaroma Pathogenesis Genes in a Drosophila Model |
University of Texas Southwestern Medical Center / Kathleen Galindo |
Young Investigator Grants |
2012 |
Texas |
Modeling and Therapeutic Targeting of p21-Activated Kinase Members in High-Risk Rhabdomyosarcoma |
Baylor College of Medicine / Jason Yustein, MD/PhD |
Innovation Grants |
2018 |
Texas |